What is tricuspid regurgitation (TR)?

Tricuspid regurgitation (TR) is a serious cardiac condition that occurs when the tricuspid valve, which regulates blood flow between the right atrium and the right ventricle, fails to close properly, causing blood to flow back into the right atrium.

TR in the wider heart valve disease landscape

Heart valve diseases affect tens of millions of patients worldwide. TR impacts over 1.6 million patients in the US and over 3 million in Europe.
 
Over the past decade, innovative minimally invasive catheter-based solutions have been developed for the treatment of aortic and mitral valve disease. However, until recently, effective minimally invasive options for TR have been limited.

 

READ MORE 
 

  • Strong clinical need for  
    transcatheter solutions for TR

  • High market potential that is  
    continuously growing

  • Strong and highly motivated team

  • Strong IP protection

  • Unique design for safe, easy and  
    quick treatment

Pioneering tricuspid valve replacement

TRiCares is a global business, with offices in France, Germany, the US and Brazil. Our vision is to bring to market a catheter-based tricuspid valve replacement system that will help patients suffering from severe tricuspid regurgitation (TR) without the need for open-heart surgery.

Press Releases